Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy.
Acetaminophen (APAP) hepatotoxicity induces endoplasmic reticulum (ER) stress which triggers the unfolded protein response (UPR) in hepatocytes. However, the mechanisms underlying ER stress remain poorly understood, thus reducing the options for exploring new pharmacological therapies for patients w...
| Autores: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2022 |
| País: | España |
| Institución: | Instituto de Salud Carlos III (ISCIII) |
| Repositorio: | Repisalud |
| Idioma: | inglés |
| OAI Identifier: | oai:repisalud.isciii.es:20.500.12105/18603 |
| Acceso en línea: | http://hdl.handle.net/20.500.12105/18603 |
| Access Level: | acceso abierto |
| Palabra clave: | Acetaminophen Animals Autophagy |
| id |
ES_5d554db1d01dbadd908630e3c1929ba9 |
|---|---|
| oai_identifier_str |
oai:repisalud.isciii.es:20.500.12105/18603 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy.Ye, HuiChen, ChaoboWu, HanghangZheng, KangMartín-Adrados, BeatrizCaparrós, EstherFrancés, RubénNelson, Leonard JGómez Del Moral, ManuelAsensio, IrisVaquero, JavierBañares, RafaelÁvila, Matías AAndrade, Raúl JIsabel Lucena, MMartínez-Chantar, Maria LuzReeves, Helen LMasson, StevenBlumberg, Richard SGracia-Sancho, JordiNevzorova, Yulia AMartínez-Naves, EduardoCubero, Francisco JavierAcetaminophenAnimalsAutophagyAcetaminophen (APAP) hepatotoxicity induces endoplasmic reticulum (ER) stress which triggers the unfolded protein response (UPR) in hepatocytes. However, the mechanisms underlying ER stress remain poorly understood, thus reducing the options for exploring new pharmacological therapies for patients with hyperacute liver injury. Eight-to-twelve-week-old C57BL/6J Xbp1-floxed (Xbp1f/f) and hepatocyte-specific knockout Xbp1 mice (Xbp1∆hepa) were challenged with either high dose APAP [500 mg/kg] and sacrificed at early (1-2 h) and late (24 h) stages of hepatotoxicity. Histopathological examination of livers, immunofluorescence and immunohistochemistry, Western blot, real time (RT)-qPCR studies and transmission electron microscopy (TEM) were performed. Pharmacological inhibition of XBP1 using pre-treatment with STF-083010 [STF, 75 mg/kg] and autophagy induction with Rapamycin [RAPA, 8 mg/kg] or blockade with Chloroquine [CQ, 60 mg/kg] was also undertaken in vivo. Cytoplasmic expression of XBP1 coincided with severity of human and murine hyperacute liver injury. Transcriptional and translational activation of the UPR and sustained activation of JNK1/2 were major events in APAP hepatotoxicity, both in a human hepatocytic cell line and in a preclinical model. Xbp1∆hepa livers showed decreased UPR and JNK1/2 activation but enhanced autophagy in response to high dose APAP. Additionally, blockade of XBP1 splicing by STF, mitigated APAP-induced liver injury and without non-specific off-target effects (e.g., CYP2E1 activity). Furthermore, enhanced autophagy might be responsible for modulating CYP2E1 activity in Xbp1∆hepa animals. Genetic and pharmacological inhibition of Xbp1 specifically in hepatocytes ameliorated APAP-induced liver injury by enhancing autophagy and decreasing CYP2E1 expression. These findings provide the basis for the therapeutic restoration of ER stress and/or induction of autophagy in patients with hyperacute liver injury.20242024-02-2720222022-02-1020222022-02-10research articlehttp://purl.org/coar/resource_type/c_2df8fbb1VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articlehttp://hdl.handle.net/20.500.12105/18603reponame:Repisaludinstname:Instituto de Salud Carlos III (ISCIII)Inglésengopen accesshttp://purl.org/coar/access_right/c_abf2Attribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:repisalud.isciii.es:20.500.12105/186032026-06-12T12:43:37Z |
| dc.title.none.fl_str_mv |
Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy. |
| title |
Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy. |
| spellingShingle |
Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy. Ye, Hui Acetaminophen Animals Autophagy |
| title_short |
Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy. |
| title_full |
Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy. |
| title_fullStr |
Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy. |
| title_full_unstemmed |
Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy. |
| title_sort |
Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy. |
| dc.creator.none.fl_str_mv |
Ye, Hui Chen, Chaobo Wu, Hanghang Zheng, Kang Martín-Adrados, Beatriz Caparrós, Esther Francés, Rubén Nelson, Leonard J Gómez Del Moral, Manuel Asensio, Iris Vaquero, Javier Bañares, Rafael Ávila, Matías A Andrade, Raúl J Isabel Lucena, M Martínez-Chantar, Maria Luz Reeves, Helen L Masson, Steven Blumberg, Richard S Gracia-Sancho, Jordi Nevzorova, Yulia A Martínez-Naves, Eduardo Cubero, Francisco Javier |
| author |
Ye, Hui |
| author_facet |
Ye, Hui Chen, Chaobo Wu, Hanghang Zheng, Kang Martín-Adrados, Beatriz Caparrós, Esther Francés, Rubén Nelson, Leonard J Gómez Del Moral, Manuel Asensio, Iris Vaquero, Javier Bañares, Rafael Ávila, Matías A Andrade, Raúl J Isabel Lucena, M Martínez-Chantar, Maria Luz Reeves, Helen L Masson, Steven Blumberg, Richard S Gracia-Sancho, Jordi Nevzorova, Yulia A Martínez-Naves, Eduardo Cubero, Francisco Javier |
| author_role |
author |
| author2 |
Chen, Chaobo Wu, Hanghang Zheng, Kang Martín-Adrados, Beatriz Caparrós, Esther Francés, Rubén Nelson, Leonard J Gómez Del Moral, Manuel Asensio, Iris Vaquero, Javier Bañares, Rafael Ávila, Matías A Andrade, Raúl J Isabel Lucena, M Martínez-Chantar, Maria Luz Reeves, Helen L Masson, Steven Blumberg, Richard S Gracia-Sancho, Jordi Nevzorova, Yulia A Martínez-Naves, Eduardo Cubero, Francisco Javier |
| author2_role |
author author author author author author author author author author author author author author author author author author author author author author |
| dc.contributor.none.fl_str_mv |
|
| dc.subject.none.fl_str_mv |
Acetaminophen Animals Autophagy |
| topic |
Acetaminophen Animals Autophagy |
| description |
Acetaminophen (APAP) hepatotoxicity induces endoplasmic reticulum (ER) stress which triggers the unfolded protein response (UPR) in hepatocytes. However, the mechanisms underlying ER stress remain poorly understood, thus reducing the options for exploring new pharmacological therapies for patients with hyperacute liver injury. Eight-to-twelve-week-old C57BL/6J Xbp1-floxed (Xbp1f/f) and hepatocyte-specific knockout Xbp1 mice (Xbp1∆hepa) were challenged with either high dose APAP [500 mg/kg] and sacrificed at early (1-2 h) and late (24 h) stages of hepatotoxicity. Histopathological examination of livers, immunofluorescence and immunohistochemistry, Western blot, real time (RT)-qPCR studies and transmission electron microscopy (TEM) were performed. Pharmacological inhibition of XBP1 using pre-treatment with STF-083010 [STF, 75 mg/kg] and autophagy induction with Rapamycin [RAPA, 8 mg/kg] or blockade with Chloroquine [CQ, 60 mg/kg] was also undertaken in vivo. Cytoplasmic expression of XBP1 coincided with severity of human and murine hyperacute liver injury. Transcriptional and translational activation of the UPR and sustained activation of JNK1/2 were major events in APAP hepatotoxicity, both in a human hepatocytic cell line and in a preclinical model. Xbp1∆hepa livers showed decreased UPR and JNK1/2 activation but enhanced autophagy in response to high dose APAP. Additionally, blockade of XBP1 splicing by STF, mitigated APAP-induced liver injury and without non-specific off-target effects (e.g., CYP2E1 activity). Furthermore, enhanced autophagy might be responsible for modulating CYP2E1 activity in Xbp1∆hepa animals. Genetic and pharmacological inhibition of Xbp1 specifically in hepatocytes ameliorated APAP-induced liver injury by enhancing autophagy and decreasing CYP2E1 expression. These findings provide the basis for the therapeutic restoration of ER stress and/or induction of autophagy in patients with hyperacute liver injury. |
| publishDate |
2022 |
| dc.date.none.fl_str_mv |
2022 2022-02-10 2022 2022-02-10 2024 2024-02-27 |
| dc.type.none.fl_str_mv |
research article http://purl.org/coar/resource_type/c_2df8fbb1 VoR http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/20.500.12105/18603 |
| url |
http://hdl.handle.net/20.500.12105/18603 |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.source.none.fl_str_mv |
reponame:Repisalud instname:Instituto de Salud Carlos III (ISCIII) |
| instname_str |
Instituto de Salud Carlos III (ISCIII) |
| reponame_str |
Repisalud |
| collection |
Repisalud |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869409007186214912 |
| score |
15,812429 |